Traub Capital Management’s Medtronic MDT Stock Holding History

Traub Capital Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-829	Closed	-$72.3K	–	369
2025 Q2	$72.3K	Buy	+829	New	+$70.3K	0.07%	202

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Traub Capital Management's MDT Position: Q3 2025 in Review

Traub Capital Management sold out of Medtronic (MDT) in Q3 2025, closing a stake of 829 shares — an estimated $72.3K sold.

Traub Capital Management first reported a position in MDT in Q2 2025 and held it in 1 quarter. The position peaked at $72.3K in Q2 2025. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

Traub Capital Management reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
Traub Capital Management sold 829 Medtronic shares in Q3 2025, an estimated $72.3K.
Traub Capital Management first reported a position in Medtronic in Q2 2025 and held it in 1 quarter.
Traub Capital Management's Medtronic position peaked at $72.3K in Q2 2025.
2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on Traub Capital Management's 13F filing for Q3 2025, filed 30 Oct 2025.